The global Peptide Vaccine Market is segmented on the basis of product type, types, application, particulate delivery methods and region. The combination of amino acids linked together by peptide bonds via the dehydration-condensation reaction results into formation of peptide molecules. Peptides can be acquired easily from the products of proteolysis, direct synthesis by the body, or artificial synthesis. Hence, Peptides play a significant role in the treatment of diseases.
Peptide vaccines comprise one or more microbial proteinaceous antigens that, when administered, elicit protective immunity against the microbial pathogen. Peptide vaccines are peptides that exhibit pharmacological properties by activating human immune system rather than showing pharmacologically activity by themselves. They are administered into body to enter in lymph nodes where they induce long lasting immune response. They utilize immune system and develop long term acquired immunity which has capability to prevent future incidences of pathogen attack.
Every living cell in human body has surface markers as an instrument to identify self from non-self which is artificially provided by vaccines. When foreign entity penetrates into the body, defense mechanism already triggered by vaccines gets activated to protect from spread of pathogen. Progress in recombinant DNA technology is the basis of development of peptide vaccine without which current progress has not been achieved by pharmaceutical companies.
Full Research Report On Global Peptide Vaccine Market Analysis available at: https://www.millioninsights.com/industry-reports/peptide-vaccine-market
Peptide vaccines include one or more short or long amino acids sequences, as an antigen combined with a vaccine adjuvant. Thus they fall in the broad category of defined antigen vaccines, along with the vaccines using proteins, protein sub units, DNA and RNA. They remain the most immunogenic approaches based on the measures of T-cell responses. Peptide immunogenicity is influenced by the way in which peptides are presented to the immune system, underscoring the need for multifunctional delivery systems that couple antigen and adjuvant into a single construct.
Based on product, the peptide vaccine market is classified into Biomarkers and NY-ESO-1.Biomarkers like Melanoma-Associated Antigen 1 for melanoma cancer vaccine and NY-ESO-1 for lung cancer are being developed. Based on type, the peptide vaccine market is classified as long peptide vaccine, multipeptide non-cocktail vaccine, peptide cocktail vaccine, hybrid peptide vaccine, personalized peptide vaccine, peptide-pulsed DC vaccine.
Hybrid peptide vaccine consists of peptide sequences of most of the single epitope vaccines as well as multi-epitope long peptide vaccines are native sequences with or without modification of anchor amino acids.Based on application, the peptide vaccine market is classified as Prostate Cancer, Breast Cancer, Gastric Cancer, Lung Cancer, and Pancreatic Cancer. Peptide vaccines for treatment and prevention of cancer are expected to occupy a major share in the global market as well as in other fields like infectious and neurobiological disease. On the basis of particulate delivery methods, the global market is classified as Emulsions, Liposomes, Virosomes, Polymeric particles, Adjuvants approved for human use.
Geographically, the peptide vaccine market is segmented into North America, China, Europe, Japan, India, and Southeast Asia. The key players in the Peptide Vaccine Market include AFFiRiS, AlerGenetica, Apitope Technology, Araclon Biotech, Artificial Cell Technologies, Benovus Bio, Immune Design, Immunocellular Therapeutics, Invectys, ISA Pharmaceuticals, Lytix Biopharma, Medinet, Merck Serono, OncoTherapy Science, and PeptiVir.
This report studies Peptide Vaccine in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering
• Antigen Express
• Apitope Technology
• Araclon Biotech
• Artificial Cell Technologies
• Benovus Bio
• Bionor Pharma
• Celgene Corporation
• Galena Biopharma
Request for Free Sample Copy at:
Market Segment by Region, this report splits Global into several key Regions, with sales, revenue, market share and growth rate of Peptide Vaccine in these regions, from 2011 to 2021 (forecast), like
• North America
• Southeast Asia
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
• Type I
• Type II
• Type III
Split by application, this report focuses on sales, market share and growth rate of Peptide Vaccine in each application, can be divided into
• Prostate Cancer
• Breast Cancer
• Gastric Cancer
• Lung Cancer
• Pancreatic Cancer
Related Reports of this Category available at Million Insights: https://www.millioninsights.com/industry/pharmaceuticals
About Million Insights
Million Insights, is a distributor of market research reports, published by premium publishers only. We have a comprehensive market place that will enable you to compare data points, before you make a purchase. Enabling informed buying is our motto and we strive hard to ensure that our clients get to browse through multiple samples, prior to an investment. Service flexibility & the fastest response time are two pillars, on which our business model is founded. Our market research report store, includes in-depth reports, from across various industry verticals, such as healthcare, technology, chemicals, food & beverages, consumer goods, material science & automotive.
For More Information: www.millioninsights.com
Company Name: Million Insights
Contact Person: Ryan Manuel
Address:Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar